Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment

J Neurol. 2020 Jul;267(7):2154-2156. doi: 10.1007/s00415-020-09940-y. Epub 2020 May 25.

Neus Mongay-Ochoa^{1

2

3}, Alberto Vogrig^{1

2}, Sergio Muñiz-Castrillo^{1

2}, Jerome Honnorat^{4

5}

¹ French Reference Center for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Lyon, France.
² Synatac Team, Institute NeuroMyoGène, INSERM U1217/CNRS UMR5310, Université de Lyon, Université Claude Bernard, Lyon 1, Lyon, France.
³ Department of Neurology, Hospital Universitari de Bellvitge, Barcelona, Spain.
⁴ French Reference Center for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Hôpital Neurologique, Lyon, France. jerome.honnorat@chu-lyon.fr.
⁵ Synatac Team, Institute NeuroMyoGène, INSERM U1217/CNRS UMR5310, Université de Lyon, Université Claude Bernard, Lyon 1, Lyon, France. jerome.honnorat@chu-lyon.fr.

No abstract available

Publication types